Back

Future perspectives in lipid lowering and CVD prevention.

27 August 2017 (13:10 - 13:30)
Organised by:
Congress Presentation Part of: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Professor Peter S Sever

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction - PCSK9 inhibitors: the next chapter in CVD prevention.
Video
Presentation thumbnail
CVD prevention and event reduction.
Professor M. Sabatine (Boston, US)
Presentation thumbnail
Panel discussion - PCSK9 inhibitors: the next chapter in CVD prevention.
Professor J. Chapman (Paris, FR)
Presentation thumbnail
Close - PCSK9 inhibitors: the next chapter in CVD prevention.
Professor J. Chapman (Paris, FR)

Access the full session

Session thumbnail
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention

The Event

Event poster

ESC Congress 2017

27 August 2017 13:10 CET
You may be interested in
thumbnail
Congress Presentation
Lipid management; Current state and future perspectives
13 April 2023
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Webinar
How to treat patients with borderline dyslipidemia
8 February 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources